132 related articles for article (PubMed ID: 16843536)
21. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death.
Hui KF; Chiang AK
Int J Cancer; 2010 May; 126(10):2479-89. PubMed ID: 19816947
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
23. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells.
Liu SF; Wang H; Lin XC; Xiang H; Deng XY; Li W; Tang M; Cao Y
Cell Biol Int; 2008 Aug; 32(8):1006-13. PubMed ID: 18579417
[TBL] [Abstract][Full Text] [Related]
24. Exposure to a 50 Hz electromagnetic field induces activation of the Epstein-Barr virus genome in latently infected human lymphoid cells.
Grimaldi S; Pasquali E; Barbatano L; Lisi A; Santoro N; Serafino A; Pozzi D
J Environ Pathol Toxicol Oncol; 1997; 16(2-3):205-7. PubMed ID: 9276003
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus and tumor promoters.
Eliasson L; Nilsson MT; Kallin B; Klein G
Princess Takamatsu Symp; 1983; 14():139-45. PubMed ID: 6097578
[TBL] [Abstract][Full Text] [Related]
26. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
Delecluse HJ; Feederle R; Behrends U; Mautner J
Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
[TBL] [Abstract][Full Text] [Related]
27. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome analysis of Burkitt lymphoma cells treated with anti-convulsant drugs that are inhibitors of Epstein-Barr virus lytic reactivation.
Gorres KL; Reineke DM; Miller G
PLoS One; 2024; 19(4):e0299198. PubMed ID: 38635661
[TBL] [Abstract][Full Text] [Related]
29. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
[TBL] [Abstract][Full Text] [Related]
30. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
Meerbach A; Friedrichs C; Thust R; Wutzler P
Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
[TBL] [Abstract][Full Text] [Related]
31. Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells.
Liu SF; Wang H; Li ZJ; Deng XY; Xiang H; Tao YG; Li W; Tang M; Cao Y
Eur J Pharmacol; 2008 Jul; 589(1-3):8-13. PubMed ID: 18571159
[TBL] [Abstract][Full Text] [Related]
32. Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression.
Feng WH; Kenney SC
Cancer Res; 2006 Sep; 66(17):8762-9. PubMed ID: 16951192
[TBL] [Abstract][Full Text] [Related]
33. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
[TBL] [Abstract][Full Text] [Related]
35. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
[TBL] [Abstract][Full Text] [Related]
36. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
37. Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.
Williams LR; Quinn LL; Rowe M; Zuo J
J Virol; 2016 Jan; 90(2):947-58. PubMed ID: 26537677
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus and systemic lupus erythematosus.
James JA; Harley JB; Scofield RH
Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus infects B and non-B lymphocytes in HIV-1-infected children and adolescents.
Bekker V; Scherpbier H; Beld M; Piriou E; van Breda A; Lange J; van Leth F; Jurriaans S; Alders S; Wertheim-van Dillen P; van Baarle D; Kuijpers T
J Infect Dis; 2006 Nov; 194(9):1323-30. PubMed ID: 17041860
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
